Vanguard Health Care ETF (VHT)
| Assets | $16.56B |
| Expense Ratio | 0.09% |
| PE Ratio | 22.43 |
| Shares Out | 82.78M |
| Dividend (ttm) | $4.70 |
| Dividend Yield | 1.75% |
| Ex-Dividend Date | Mar 24, 2026 |
| Payout Ratio | 39.21% |
| 1-Year Return | +6.90% |
| Volume | 164,778 |
| Open | 270.55 |
| Previous Close | 268.78 |
| Day's Range | 268.04 - 271.06 |
| 52-Week Low | 234.13 |
| 52-Week High | 298.61 |
| Beta | 0.68 |
| Holdings | 413 |
| Inception Date | Jan 26, 2004 |
About VHT
Fund Home PageThe Vanguard Health Care ETF (VHT) is an exchange-traded fund that is based on the MSCI US IMI 25/50 Health Care indexThe fund tracks a market-cap-weighted index of US healthcare stocks VHT was launched on Jan 26, 2004 and is issued by Vanguard.
Top 10 Holdings
50.46% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 11.89% |
| Johnson & Johnson | JNJ | 9.34% |
| AbbVie Inc. | ABBV | 6.18% |
| Merck & Co., Inc. | MRK | 4.80% |
| UnitedHealth Group Incorporated | UNH | 3.94% |
| Amgen Inc. | AMGN | 3.05% |
| Thermo Fisher Scientific Inc. | TMO | 2.97% |
| Abbott Laboratories | ABT | 2.87% |
| Gilead Sciences, Inc. | GILD | 2.78% |
| Intuitive Surgical, Inc. | ISRG | 2.63% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 24, 2026 | $0.994 | Mar 26, 2026 |
| Dec 17, 2025 | $1.6654 | Dec 19, 2025 |
| Sep 24, 2025 | $1.0765 | Sep 26, 2025 |
| Jun 26, 2025 | $0.9619 | Jun 30, 2025 |
| Mar 25, 2025 | $0.9396 | Mar 27, 2025 |
| Dec 18, 2024 | $0.9188 | Dec 20, 2024 |
News
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight
Health care ETFs could emerge as one of the stronger performers in 2026 as investors grow cautious about pricey AI stocks.
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus
The approval of Novo Nordisk's (NYSE: NVO)oral Wegovy is bringing new interest to health care and pharmaceutical ETFs that provide access to the growing GLP-1 market without requiring investors to cho...
Best blue-chip ETFs to buy as Donald Trump's trade war escalates
American stocks have crashed this year, and are continuing to lag behind their global peers in countries like Germany, France, and China. This performance may continue next week when Trump implements ...
Pharma market investments: How ETFs help you dabble in the sector at a modest price
Some health care sector ETFs have exposure to companies like Johnson & Johnson, Pfizer, UnitedHealth
Top 3 contrarian ETFs as the Fed prepares to raise interest rates
The Federal Reserve is expected to start hiking interest rates in March – or earlier – as consumer inflation jumps. A hawkish Fed is expected to have major implications for top assets like stocks and ...
Charts Suggest Healthcare Stocks Will Remain in Focus
Chart patterns suggest that focus should expand from the biotechs and drug makers to other niche healthcare segments.
Health-care ETFs win the week as Biden presidency affirms Obamacare
Health-care exchange-traded funds ticked down fractionally in Friday morning trading, but were still on track to be the top performing sector for the week.
A Strategy For Buying The Dip In Health Care ETFs
In an update to his original November strategy of getting investing in health care, the Viper Report’s Tom Aspray shares his technical outlook on three of the sector’s key ETFs.
Healthcare Investors - Buy More On A Dip
As the major averages continue to make new highs, one sector that stood out in November is still acting strong.
Healthcare Investors Take Note
The major breakouts in several of the health care ETFs were a reason to buy in November and Tom Aspray takes a new look at their charts.
3 Ways To Invest $2000 in Healthcare
With the major averages at new all-time highs, Tom Aspray still likes the potential of three health care ETFs. He explains why he likes these three and proposes a strategy for getting invested in the...
3 Charts Suggest Health Care Stocks Are Headed Higher
Bullish chart patterns suggest that active traders will be looking for health care stocks to make a major long-term move higher.
Biotech stocks fall after Trump promises executive order drug prices
CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.
Health-care stocks could rebound after their worst week of the year
Health care's sharp drop comes as investors worry that left-leaning policy ideas like universal health coverage are gaining support.